Out of the Blue: An AJRCCM Podcast
Total duration:
16 h 55 min
A New Global Definition of Acute Respiratory Distress Syndrome
Out of the Blue: An AJRCCM Podcast
33:04
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease
Out of the Blue: An AJRCCM Podcast
45:40
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Out of the Blue: An AJRCCM Podcast
16:04
Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment
Out of the Blue: An AJRCCM Podcast
34:40
A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea
Out of the Blue: An AJRCCM Podcast
23:59
Progressive Early Interstitial Lung Abnormalities in Persons At-Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study and Big Things Have Small Beginnings: Clinical Implications of Early In
Out of the Blue: An AJRCCM Podcast
26:37
Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement
Out of the Blue: An AJRCCM Podcast
23:36
Hypnotics on Obstructive Sleep Apnea Severity and Endotypes: A Systematic Review and Meta-Analysis and The Arousal Threshold: The ‘Weakest Link’ in OSA Pathogenesis?
Out of the Blue: An AJRCCM Podcast
37:26
Evaluation of Etomidate Use and Association with Mortality Compared with Ketamine among Critically Ill Patients
Out of the Blue: An AJRCCM Podcast
33:14
From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations for Developing Precision Medicine in the ICU
Out of the Blue: An AJRCCM Podcast
27:16
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease
Out of the Blue: An AJRCCM Podcast
21:02
Senolytic-facilitated Reversal of End-Organ Dysfunction in a Murine Model of Obstructive Sleep Apnea
Out of the Blue: An AJRCCM Podcast
32:44
Effectiveness of Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone in Septic Shock: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Out of the Blue: An AJRCCM Podcast
20:49
Inhalable Textile Microplastic Fibers Impair Airway Epithelial Differentiation and Inhaled Microplastics and Airway Development: Concerning Evidence from Organoids
Out of the Blue: An AJRCCM Podcast
25:59
A New Global Definition of Acute Respiratory Distress Syndrome
Out of the Blue: An AJRCCM Podcast
33:05
External Control Arms in Idiopathic Pulmonary Fibrosis Using Clinical Trial and Real-World Data Sources and The Added Power of Synthetic Control Groups: Challenging Conventional Wisdom and Trial Desig
Out of the Blue: An AJRCCM Podcast
32:50
The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial and Pharmacologic Therapy for Obstructive Sleep Apnea: Are We Seei
Out of the Blue: An AJRCCM Podcast
22:43
FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease
Out of the Blue: An AJRCCM Podcast
16:21
Conservative versus Liberal Oxygenation Targets in Intensive Care Unit Patients (ICONIC): A Randomized Clinical Trial
Out of the Blue: An AJRCCM Podcast
17:14
Pulse Wave Amplitude Drops Index: A Biomarker of Cardiovascular Risk in Obstructive Sleep Apnea
Out of the Blue: An AJRCCM Podcast
20:38
Individualized Treatment Effects of Bougie vs Stylet for Tracheal Intubation in Critical Illness
Out of the Blue: An AJRCCM Podcast
25:09
Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
Out of the Blue: An AJRCCM Podcast
22:10
Dexmedetomidine and Propofol Sedation in Critically Ill Patients and Dose Associated 90-day Mortality: A Secondary Cohort Analysis of a Randomized Controlled Trial (SPICE-III)
Out of the Blue: An AJRCCM Podcast
33:19
Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California
Out of the Blue: An AJRCCM Podcast
17:48
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
Out of the Blue: An AJRCCM Podcast
14:59
Cardiovascular Benefit of Continuous Positive Airway Pressure in Adults with Coronary Artery Disease and Obstructive Sleep Apnea without Excessive Sleepiness
Out of the Blue: An AJRCCM Podcast
24:03
High-Flow Versus VenturiMask Oxygen Therapy to Prevent Re-Intubation in Hypoxemic Patients After Extubation: A Multicenter, Randomized Clinical Trial
Out of the Blue: An AJRCCM Podcast
28:24
Autoimmune Pulmonary Alveolar Proteinosis
Out of the Blue: An AJRCCM Podcast
21:47
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis
Out of the Blue: An AJRCCM Podcast
27:31
Coarse Particulate Air Pollution and Daily Mortality: A Global Study in 205 Cities
Out of the Blue: An AJRCCM Podcast
25:55
A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea
Out of the Blue: An AJRCCM Podcast
23:58
Liberation from Invasive Mechanical Ventilation with Continued Receipt of Vasopressor Infusions
Out of the Blue: An AJRCCM Podcast
17:26
Effect of Weight Loss and CPAP on OSA and Metabolic Profile Stratified by Craniofacial Phenotype
Out of the Blue: An AJRCCM Podcast
20:05
Using Isoniazid More Safely and More Effectively in Tuberculosis Treatment
Out of the Blue: An AJRCCM Podcast
34:39
Multi-night Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea
Out of the Blue: An AJRCCM Podcast
20:53
Alpha-1 Antitrypsin MZ Heterozygosity is an Endotype of COPD
Out of the Blue: An AJRCCM Podcast
12:19
Latent Class Analysis in COVID-19
Out of the Blue: An AJRCCM Podcast
41:22
Effect of Esophageal Pressure-Guided Positive End-Expiratory Pressure on Survival from ARDS
Out of the Blue: An AJRCCM Podcast
18:23
Association Between PAP Device Manufacturer and Incident Cancer?: A Secondary Data Analysis
Out of the Blue: An AJRCCM Podcast
21:48
Association between Troponin I Levels during Sepsis and Postsepsis Cardiovascular Complications
Out of the Blue: An AJRCCM Podcast
18:50
